Federal authorities say wholesale drug distributor McKesson Corp. will pay more than $190 million to settle claims that it led Medicaid to overpay for drugs by reporting inflated prices to a publisher.
New Jersey U.S. Attorney Paul Fishman and other officials said Thursday that McKesson marked up the average drug prices it reported to publisher First DataBank by 25 percent between 2001 and 2005.
Most state Medicaid programs use First DataBank information to determine what they pay for drugs.
Authorities say Medicaid ended up paying too much for a variety of brand-name pharmaceuticals that McKesson sells. They said the alleged scheme violated the False Claims Act.
In a statement, McKesson denied manipulating drug prices or violating any law. It said it settled to avoid the costs and uncertainty of litigation.
Elon Musk’s Crony Capitalism under Scrutiny | Human Events
WaPo: Yeah, Hillary sent six e-mails with classified material — so far - Hot Air
Nick Adams - Not a Single Illegal Immigrant in 7 Months... In Australia
'Why hasn't Hillary been charged?' Andrea Tantaros has questions about Clinton email 'coverup'
Michelle Malkin - Eric Cantor: Poster Boy of the Beltway GOP Crapweasels
FATAL SELFIE: Teen Killed Taking Instagram Photo With Gun To His Head - Bearing Arms - Negligent Discharge, Texas
Have We Not More Faith Than This? | RedState